Mauro Papotti

Prof. Mauro Papotti

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2022 in Endocrine Pathology
Verified
Journal Article
Closed access
PDF file
ZBZubair W. Baloch
Zubair W. Baloch
Sylvia L. AsaSylvia L. Asa
Sylvia L. Asa
JBJustine A. Barletta
Justine A. Barletta
RGRonald A. Ghossein
Ronald A. Ghossein
CJCarl Christofer Juhlin
Carl Christofer Juhlin
OMOzgur Mete
Ozgur Mete

16 March 2022 in Endocrine Pathology
Verified
Journal Article
Closed access
PDF file
Guido RindiGuido Rindi
Guido Rindi
OMOzgur Mete
Ozgur Mete
SUSilvia Uccella
Silvia Uccella
Olca BasturkOlca Basturk
Olca Basturk
SRStefano La Rosa
Stefano La Rosa
Sylvia L. AsaSylvia L. Asa
Sylvia L. Asa

14 March 2022 in Endocrine Pathology
Verified
Journal Article
Closed access
PDF file
OMOzgur Mete
Ozgur Mete
LELori A. Erickson
Lori A. Erickson
CJCarl Christofer Juhlin
Carl Christofer Juhlin
Ronald de KrijgerRonald de Krijger
Ronald de Krijger
HSHironobu Sasano
Hironobu Sasano
MPMauro Papotti
Mauro Papotti

1 May 2002 in Virchows Archiv
Verified
Journal Article
Closed access
PDF file
MPMauro Papotti
Mauro Papotti
MBMassimo Bongiovanni
Massimo Bongiovanni
MVM. Volante
M. Volante
EAE. Allìa
E. Allìa
SLStefania Landolfi
Stefania Landolfi
GBG. Bussolati
G. Bussolati

26 January 2004 in Cancer
Verified
Journal Article
Closed access
PDF file
MVMarco Volante
Marco Volante
SLStefania Landolfi
Stefania Landolfi
LCLuigi Chiusa
Luigi Chiusa
NPNicola Palestini
Nicola Palestini
MMManuela Motta
Manuela Motta
MPMauro Papotti
Mauro Papotti

1 August 2016 in Human Pathology
Verified
Journal Article
Open access
FMFrancesca Maletta
Francesca Maletta
FMFederica Massa
Federica Massa
LTLiborio Torregrossa
Liborio Torregrossa
EDEleonora Duregon
Eleonora Duregon
GCGian Piero Casadei
Gian Piero Casadei
MPMauro Papotti
Mauro Papotti
Among thyroid papillary carcinomas (PTCs), the follicular variant is the most common and includes encapsulated forms (EFVPTCs). Noninvasive EFVPTCs have very low risk of recurrence or other adverse events and have been recently proposed to be designated as noninvasive follicular thyroid neoplasm with papillary-like nuclear features or NIFTP, thus eliminating the term carcinoma. This proposal is expected to significantly impact the risk of malignancy associated with the currently used diagnostic categories of thyroid cytology. In this study, we analyzed the fine needle aspiration biopsy (FNAB) cytology features of 96 histologically proven NIFTPs and determined how the main nuclear features of NIFTP correlate between cytological and histological samples. Blind review of FNAB cytology from NIFTP nodules yielded the diagnosis of "follicular neoplasm" (Bethesda category IV) in 56% of cases, "suspicious for malignancy" (category V) in 27%, "atypia of undetermined significance/follicular lesion of undetermined significance" (category III) in 15%, and "malignant" (category VI) in 2%. We found good correlation (κ=0.62) of nuclear features between histological and cytological specimens. NIFTP nuclear features (size, irregularities of contours, and chromatin clearing) were significantly different from those of benign nodules but not from those of invasive EFVPTC. Our data indicate that most of the NIFTP nodules yield an indeterminate cytological diagnosis in FNAB cytology and nuclear features found in cytology samples are reproducibly identified in corresponding histology samples. Because of the overlapping nuclear features with invasive EFVPTC, NIFTP cannot be reliably diagnosed preoperatively but should be listed in differential diagnosis of all indeterminate categories of thyroid cytology.